Tata Memorial Hospital
Mumbai, Maharashtra, India
27 recruiting
Showing 1–20 of 26 trials
Recruiting
Phase 3
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Locally Advanced Head and Neck Squamous Cell CarcinomaAged
Johnson & Johnson Enterprise Innovation Inc.500 enrolled189 locationsNCT04892173
Recruiting
Phase 4
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
Multiple Myeloma
Johnson & Johnson Private Limited75 enrolled12 locationsNCT07030517
Recruiting
Phase 3
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Bristol-Myers Squibb1,000 enrolled280 locationsNCT06561386
Recruiting
Phase 3
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
Breast Cancer
Pfizer1,020 enrolled518 locationsNCT06760637
Recruiting
Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Germ Cell TumorChildhood Extracranial Germ Cell TumorExtragonadal Embryonal Carcinoma+27 more
Children's Oncology Group1,780 enrolled630 locationsNCT03067181
Recruiting
Phase 3
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Biliary Tract Cancer
Jazz Pharmaceuticals286 enrolled183 locationsNCT06282575
Recruiting
Not Applicable
Palliative Radiation for Advanced Cervical Cancer
Cervical Cancer
Tata Memorial Hospital230 enrolled1 locationNCT03997110
Recruiting
Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.
SurgeryChemotherapyMetastasis+4 more
Tata Memorial Hospital350 enrolled1 locationNCT07400809
Recruiting
Phase 3
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Janssen Research & Development, LLC1,000 enrolled231 locationsNCT06662786
Recruiting
Phase 3
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Janssen Research & Development, LLC700 enrolled229 locationsNCT06750094
Recruiting
Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India
Gynecologic CancersCervical Cancer ScreeningChemoradiotherapy+1 more
Tata Memorial Hospital618 enrolled2 locationsNCT07290972
Recruiting
Clinical Outcomes and Quality of Life in Patients With Locally Advanced Vulvovaginal Cancers: Ambispective Registration Study.
Vulvo-vaginal Cancer
Tata Memorial Hospital200 enrolled1 locationNCT07179757
Recruiting
Phase 4
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
Non-metastatic Castration-resistant Prostate Cancer
Bayer50 enrolled25 locationsNCT05348876
Recruiting
Not Applicable
Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT)
Brain Tumor, Pediatric
Tata Memorial Centre94 enrolled1 locationNCT07338526
Recruiting
Phase 1
Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma
Relapsed Advanced Lymphomas
Aurigene Discovery Technologies Limited40 enrolled19 locationsNCT06755450
Recruiting
Phase 3
Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
Asymptomatic Brain MetastasesDriver Mutation Positive Non-small Cell Lung Cancer
Tata Memorial Hospital190 enrolled1 locationNCT05236946
Recruiting
Phase 2
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
Non-small Cell Lung CancerOligometastatic DiseaseDriver Mutation
Tata Memorial Hospital106 enrolled1 locationNCT05277844
Recruiting
Not Applicable
Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
Sentinel Lymph Node Biopsy (SLNB)Sentinel Lymph NodeSentinel Lymph Node Biopsy+4 more
Tata Memorial Hospital508 enrolled3 locationsNCT05774483
Recruiting
Not Applicable
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
Cervical CancerEndometrial Cancer
Tata Memorial Centre90 enrolled2 locationsNCT05857631
Recruiting
Tracing Brain Tumors Through Deep Time
OncologyBrain Tumor
Tata Memorial Centre10,000 enrolled1 locationNCT06381531